- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Kerry Hilton, HC&B HEALTHCARE COMMUNICATIONS
It used to be that sacrificing one's own health was not an option. So now new responsibility has emerged for marketers.
Kerry Hilton
PRESIDENT AND CEO | HC&B HEALTHCARE COMMUNICATIONS
It used to be that sacrificing one's own health was not an option. So now new responsibility has emerged for marketers. A new heightened need to educate is here. What are the benefits of sticking to your regimen? What are the dangers of stopping? How can you prioritize your lifestyle to put healthcare first? This dialogue can best be facilitated via the Web with accountability diaries that reward compliance or provide discounts. It's our responsibility to educate and encourage with new kinds of innovative communications.
Kerry Hilton
A much more stringent review of online messaging is most likely coming. Various rules will apply for display ads, rich media ads, banners, etc., depending on the real estate they occupy. I personally would like to see the industry step forward and lead this discussion with recommended guidelines now. This proactive approach will define the future rather than have it defined for us. Why not partner with Google? Let's merge together the future of online health with online health marketing.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
